Grace Therapeutics, Inc.

GRCE

$2.13

-0.47%

N/A-$0.01

Healthcare

Biotechnology

NASDAQ

Active Trading

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in ...

Historical Employee Count of GRCE

Current

Change

-16.67%

Minimum

Maximum

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Mar 31, 2026	5	10-K	Jun 18, 2026	View
Mar 31, 2025	6	10-K	Jun 23, 2025	View
Mar 31, 2024	4	10-K	Jun 21, 2024	View
Mar 31, 2023	3	10-K	Jun 23, 2023	View
Mar 31, 2022	3	10-K	Jun 21, 2022	View

Supply Chain of GRCE

Upstream / Downstream / Proxies

Upstream

WuXi Clinical (WuXi AppTec)HKEx:2359Contract Manufacturing Organization (CMO) — UnnamedUnconfirmedAPI / Nimodipine Raw Material Supplier(s)Primary Packaging & Container Supplier(s)WuXi AppTec Sub-Suppliers (Lab Equipment, Reagents, Raw Materials)

Downstream

Hospital Neuro-ICU Centers (Potential Future Customers)Hospital Wholesale / Specialty Distributors (Potential)Potential Strategic Commercialization Partner

Proxies

Amylyx Pharmaceuticals, Inc.NASDAQ:AMLX Catalyst Pharmaceuticals, Inc.NASDAQ:CPRX Harmony Biosciences Holdings, Inc.NASDAQ:HRMY

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer